| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_a4afb11b9038232a630fc22a300b2717 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P19-10
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/B65B63-08
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-0019
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P5-18
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P5-20
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P43-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/B65B55-10
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K38-29
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/B65B55-12
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-19
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K14-635
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N30-7233 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K38-22
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K14-575
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P5-18
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-19
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P19-10 |
| filingDate |
2016-06-23-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_0c401c3a00ea62f3ca5a3418b476e58d
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_056c4365e0a4b4d422c743917e2d265a
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_b4c40e4b0dc7cb8585fcc230c8c95e85 |
| publicationDate |
2016-09-29-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
JP-2016172765-A |
| titleOfInvention |
Lyophilized preparation containing high purity PTH and method for producing the same |
| abstract |
PROBLEM TO BE SOLVED: To provide a freeze-dried preparation containing high-purity PTH peptide and a production method thereof. Further, the present invention provides a method for examining a PTH related substance for confirming the purity of a lyophilized preparation containing a PTH peptide. Existence was confirmed. Furthermore, it discovered that the production | generation of the said PTH related substance was prevented and reduced notably by suppressing exposure to the air environment in pharmaceutical manufacturing facilities, such as a PTH peptide containing solution. [Selection] Figure 2 |
| priorityDate |
2011-06-07-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |